Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 History  





2 Legal status  





3 See also  





4 References  














MON 863: Difference between revisions






Dansk
Français
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 





Help
 

From Wikipedia, the free encyclopedia
 


Browse history interactively
 Previous edit
Content deleted Content added
No edit summary
Citation bot (talk | contribs)
5,018,759 edits
Alter: title. Removed parameters. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 178/193
 
(89 intermediate revisions by 42 users not shown)
Line 1: Line 1:

{{Short description|Variety of maize}}

{{pov-section|date=January 2010}}

'''MON 863''' is a [[Genetically modified maize|genetically engineered variety of maize]] produced by [[Monsanto]]. It is genetically altered to express a modified version of [[Cry3Bb1]], a delta endotoxin which originates from ''[[Bacillus thuringiensis]]''.<ref name='Greenpeace MON863 chronicle'>{{cite web | url = http://www.greenpeace.org/international/Global/international/planet-2/report/2007/3/mon863_chronicle_of_deception.pdf | title = The MON863 case - a chronicle of systematic deception | access-date = 2010-07-22 | publisher = [[Greenpeace]] | quote = MON863 is a genetically modified corn that expresses a Bt-toxin. This toxin is a modified version of the delta endotoxin Cry3Bb1 which originates from the microorganism Bacillus thuringiensis. The genetic manipulation is aimed at protecting maize plants against a pest called corn rootworm (Diabrotica spp.). MON863 differs from other Bt-corns already placed on the market (MON810, BT11, Bt176), which produce a modified Cry1Ab toxin conferring resistance to a pest called European corn borer (Ostrinia nubilalis), in that it produces an artificial Cry3Bb1 toxin. In addition to the modified Cry3Bb1 toxin gene MON863 contains an antibiotic resistance marker gene.}}</ref><ref name='Doull 2007 genetics'>{{cite journal |doi=10.1016/j.fct.2007.08.033 |title=Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863) |year=2007 |last1=Doull |first1=J. |last2=Gaylor |first2=D. |last3=Greim |first3=H.A. |last4=Lovell |first4=D.P. |last5=Lynch |first5=B. |last6=Munro |first6=I.C. |journal=[[Food and Chemical Toxicology]] |volume=45 |issue=11 |pages=2073–85 |pmid=17900781}}</ref> This protects the plant from [[Diabrotica|corn rootworm]].<ref name='Doull 2007 genetics' /><ref name='Coghlan 2010-01-22'>{{cite news | first = Andy | last = Coghlan | title = Engineered maize toxicity claims roundly rebuffed | date = 2010-01-22 | url = https://www.newscientist.com/article/mg20527444.000-engineered-maize-toxicity-claims-roundly-rebuffed.html | work = New Scientist | access-date = 2010-07-21}}</ref> Unlike [[MON 810]], [[Bt 11]], and [[Bt 176]] which each produce a modified [[Cry1Ab]], MON 863 instead produces a modified Cry3Bb1 toxin and contains [[nptII]], a [[marker gene]] for [[antibiotic resistance]].<ref name='Greenpeace MON863 chronicle' /><ref name='Lorch 2005-09-30'>{{cite web | url = http://www.ifrik.org/files-ifrik/0509_greenpeace_mon863_hybrids.pdf | title = EFSA's Opinion on MON863 hybrids | access-date = 2010-07-22 | last = Lorch | first = Antje | date = 2005-09-30 | work = ifrik | publisher = [[Greenpeace]] | quote = MON863 contains an GM antibiotic resistance gene (nptII) against kanamycin and neomycin. | url-status = dead | archive-url = https://web.archive.org/web/20110726171634/http://www.ifrik.org/files-ifrik/0509_greenpeace_mon863_hybrids.pdf | archive-date = 2011-07-26 }}</ref>

{{cleanup|section|date=July 2010}}

'''MON 863''' is a [[genetically modified]] (GM) variety of maize produced by [[Monsanto Company]] and approved for human consumption in the [[European Union]].


In 1989 a 90-day rat-feeding trial done by the FDA, 40 rats that were fed the Bt corn developed multiple reactions typically found in response to allergies, infections, toxins and diseases. Seralini et al.<ref>{{cite web

|url=http://www.springerlink.com/content/02648wu132m07804/

|title=New Analysis of a Rat Feeding Study with a Genetically Modified Maize Reveals Signs of Hepatorenal Toxicity

|publisher=

|accessdate=2010-01-13

|last=

|first=

}}</ref> reviewed the study as part of the French Commission for Biomolecular Genetics and said that the response by the rats were similar to reactions caused by pesticides. Although the Bt-toxin is a pesticide, he points out that animal research on pesticide-producing corn is nowhere as thorough as that required for approval of pesticides. Follow-up studies on these serious findings were demanded from organisations worldwide. None were conducted and the corn was approved.


Monsanto defended its corn's safety in ways that disregarded accepted scientific methods and principles and claimed that the results of this study were not statistically significant. Monsanto researchers used six additional control groups, each fed commercial corn varieties with quite different genetics. While such comparisons are suitable for commercial studies, they are entirely inappropriate for safety assessments. Monsanto claimed that since some reactions were no longer significant when compared to these other groups, the changes were unimportant. For some results, that remained statistically significant even when compared to these irrelevant controls, Monsanto claimed the changes fell within a wide range of variability that is normal for rats. They stated, for example, that a 52% decrease in immature red blood cells (reticulocytes) was "attributable to normal biological variability", and a 10% increase in blood sugar levels was biologically insignificant. According to Arpad Pusztai an allowance of 5% variability is the norm in food experiments and a 10% rise in blood sugar has serious ramifications, given the epidemics of obesity and diabetes. Several changes were still significantly outside the generous range that Monsanto defined as normal and acceptable. For some of these, they claimed that the health effects were not diet-related because the reactions were not consistent between males and females. (Scientists studying cancer and endocrinology, for example, have established that genders can respond to toxins and disease quite differently). Monsanto also dismissed other findings on the basis that the intensity of reactions was greater in rats fed a diet with 11% of MON 863 compared to the group that ate 33%. (In endocrinology and immunology research responses are not always consistent with dosage. For example, a small amount of a hormone can cause a woman to ovulate, while a larger dose can make her infertile.)


An Appeal Court action in Germany (Münster) allowed public access in June 2005 to all the crude data from the original 90-day rat-feeding study.


In 2007, a reanalysis of the data provided in 2002 by Monsanto stated that "with the present data it cannot be concluded that GM corn MON 863 is a safe product."<ref>{{cite journal |author=Gilles-Eric Seralini; Dominique Cellier; Joel Spiroux de Vendomois |title=New Analysis of a Rat Feeding Study with a Genetically Modified Maize Reveals Signs of Hepatorenal Toxicity |journal=Environmental Contamination and Toxicology |volume=52 |pages=596–602 |date=2007 |publisher=Springer}}</ref> The French biomolecular engineering commission, the ''Commission du Génie Biomoléculaire'' (CGB), reviewed this study at the request of the French Ministry of Agriculture, but concluded that there were no new elements proving the toxicity of MON 863 in this new analysis, the statistical significance of the initial samples provided by Monsanto being too weak.<ref>[http://www.ogm.gouv.fr/experimentations/evaluation_scientifique/cgb/autres_avis/Avis_CGB_MON863_15juin2007.pdf Report from the CGB].</ref>


The Australian government analyzed the data and determined that the variations found were due to normal physiologic variation in test animals and also licensed MON 863 for food and feed use.<ref>{{cite web

|url=http://www.foodstandards.gov.au/newsroom/factsheets/factsheets2007/updatemon863cornsafe3508.cfm

|title=Update: MON863 corn safety assessment

|publisher=Food Standards Australia New Zealand (FSANZ)

|accessdate=2010-01-13

|last=

|first=

}}</ref><ref>{{cite web

|url=http://www.foodstandards.gov.au/_srcfiles/Assessment%20MON863%20feeding%20study.pdf

|title=Review of 13-Week Rat Feeding Study with MON863 Corn

|publisher=Food Standards Australia New Zealand (FSANZ)

|accessdate=2010-01-13

|last=

|first=

}}</ref>



==History==

==History==

In 2004, Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed<ref>Staff (8 August 2005) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_feed.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm] {{Webarchive|url=https://web.archive.org/web/20101231200535/http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_feed.pdf |date=2010-12-31 }} Commission of the European Communities, Official Journal, Retrieved 17 November 2012</ref> and in 2006 for use in food.<ref>Staff (13 January 2006) [http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_food.pdf concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm and in 2006 in food] {{Webarchive|url=https://web.archive.org/web/20120905152527/http://www.gmo-compass.org/pdf/regulation/maize/MON863_maize_decision_food.pdf |date=2012-09-05 }} Commission of the European Communities, Official Journal, Retrieved 17 November 2012</ref> There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr [[Gilles-Éric Séralini]], who was on the committee that reviewed MON863 for the French government.<ref>{{Cite web |url=http://www.criigen.org/SiteEn/index.php?option=com_content&task=view&id=57&Itemid=105 |title=Seralini bio on CRIIGEN |access-date=2012-09-22 |archive-url=https://web.archive.org/web/20140330131455/http://www.criigen.org/SiteEn/index.php?option=com_content&task=view&id=57&Itemid=105 |archive-date=2014-03-30 |url-status=dead }}</ref>

Following legal action by parties including the [[Swedish Board of Agriculture]] and [[Greenpeace]], a [[Münster]] appeals court ruled that Monsanto would be forced to publicly reveal its research data.<ref name='Reilly 2010-01-23'> {{cite news | first = Michael | last = Reilly | title = Is Genetically Modified Corn Toxic? | date = 2010-01-23 | url = http://news.discovery.com/earth/is-genetically-modified-corn-toxic.html | work = Discovery News | accessdate = 2010-07-21}}</ref>



See [[genetically_modified_food_controversies#S.C3.A9ralini_criticisms_of_toxicity_study_designs_and_responses|Genetically modified food controversies]] for details of this controversy, which extended beyond MON 863.

==Modified mechanisms==

MON 863 was engineered to contain genes for modified ''[[Bacillus thuringiensis]]'' [[Cry3Bb1]] protein.<ref name='Doull 2007 genetics'> {{cite journal | title = Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863). | journal = Food and Chemical Toxicology | date = November 2007 | first = J. | last = Doull | coauthors = D. Gaylor, H.A. Greim, D.P. Lovell, B. Lynch, I.C. Munro | volume = 45 | issue = 11 | pages = 2073-2085| id = PMID 17900781 {{doi | 10.1016/j.fct.2007.08.033}} | url = http://www.ask-force.org/web/Food/Doull-Report-Seralini-2007.pdf | format = PDF | accessdate = 2010-07-21|quote=MON 863, a genetically engineered corn variety that contains the gene for modified Bacillus thuringiensis Cry3Bb1 protein to protect against corn rootworm, was tested in a 90-day toxicity study as part of the process to gain regulatory approval.}}</ref> This protects the plant from [[corn rootworm]] and [[European Corn Borer]] larvae.<ref name='Doull 2007 genetics' /><ref name='Coghlan 2010-01-22'> {{cite news | first = Andy | last = Coghlan | title = Engineered maize toxicity claims roundly rebuffed | date = 2010-01-22 | url = http://www.newscientist.com/article/mg20527444.000-engineered-maize-toxicity-claims-roundly-rebuffed.html | work = New Scientist | accessdate = 2010-07-21}}</ref>



Following legal action by parties including the [[Swedish Board of Agriculture]] and [[Greenpeace]], a [[Münster]] appeals court ruled that Monsanto would be forced to publicly reveal its research data.<ref name='Reilly 2010-01-23'>{{cite news | first = Michael | last = Reilly | title = Is Genetically Modified Corn Toxic? | date = 2010-01-23 | url = http://news.discovery.com/earth/is-genetically-modified-corn-toxic.html | work = Discovery News | access-date = 2010-07-21}}</ref>

==Effects of consumption==

Monsanto's research data was analyzed in 2007 by researchers from the [[Committee of Independent Research and Information on Genetic Engineering]], [[University of Caen Lower Normandy|Caen University]] and the [[University of Rouen]].<ref name='TGR'> {{cite web | url = http://www.youtube.com/watch?v=Qpq6C4VND0A | title = Monsanto GMOs Linked To Organ Failure | accessdate = 2010-07-21 | date = 2010-01-07 | work = The Global Report | publisher = [[YouTube]]}}</ref><ref name='Z Magazine Ananda 2010'> {{cite journal | title = Three Approved GMOs Linked to Organ Damage | journal = Z Magazine | date = 2010 | first = Rady | last = Ananda | volume = 23 | issue = 3| id = | url = http://www.zcommunications.org/three-approved-gmos-linked-to-organ-damage-by-rady-ananda.pdf | format = PDF | accessdate = 2010-07-21|quote=The data "clearly underlines adverse impacts on kidneys and liver, the dietary detoxifying organs, as well as different levels of damages to heart, adrenal glands, spleen, and haematopoietic system," reported Gilles-Eric Séralini, a molecular biologist at Caen University.}}</ref> This study concluded that experiments longer than 90-days must be conducted before the safety of MON 863 can be known.<ref name='Seralini 2007-03-13'> {{cite journal | title = New Analysis of a Rat Feeding Study with a Genetically Modified Maize Reveals Signs of Hepatorenal Toxicity | journal = Archives of Environmental Contamination and Toxicology | date = 2007-03-13 | first = Gilles-Eric | last = Séralini | coauthors = Dominique Cellier, Joël Spiroux de Vendomois | volume = 52 | issue = 4 | pages = 596-602| id = PMID 17356802 {{doi | 10.1007/s00244-006-0149-5}} | accessdate = 2010-07-21|quote=Longer experiments are essential in order to indicate the real nature and extent of the possible pathology; with the present data it cannot be concluded that GM corn MON863 is a safe product}}</ref> Furthermore, according to Séralini, the data is clear in that MON 863 adversely affects [[liver]] and [[kidney]] function, as well as causes varying degrees of damage to the [[adrenal glands]], [[heart]], [[spleen]], and other components of the haematopoietic system.<ref name='Z Magazine Ananda 2010' /> Following the study, a panel was formed to investigate the study, which objected to the study's findings.<ref name='Doull 2007 conclusions'> {{cite journal | title = Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863). | journal = Food and Chemical Toxicology | date = November 2007 | first = J. | last = Doull | coauthors = D. Gaylor, H.A. Greim, D.P. Lovell, B. Lynch, I.C. Munro | volume = 45 | issue = 11 | pages = 2073-2085| id = PMID 17900781 {{doi | 10.1016/j.fct.2007.08.033}} | url = http://www.ask-force.org/web/Food/Doull-Report-Seralini-2007.pdf | format = PDF | accessdate = 2010-07-21|quote=The Se´ralini et al. reanalysis does not advance any new scientific data to indicate that MON 863 caused adverse effects in the 90-day rat study.}}</ref> The panel's critical claims were also the subject of a subsequent article in ''[[Le Figaro]]'', titled "''European Experts claim GMO is harmless''", to which Séralini responded: "Our paper was not particularly alarmist, but by far, one of the longest and most detailed study ever published on a toxicological analysis on mammals consuming a commercialized GMO." "39 signs of toxicity were observed on the livers and kidneys of the laboratory mammals consuming genetically modified (GM) maize MON863 over a 3 month period", and "there is confirmed tissue damage after the consumption of the MON863 GM maize, in the kidneys of young male rats aged 5 months, with a chronic nephropathy at stage 18/20 (the non-GM control group was only 14/20). This was also described by the Monsanto team themselves and then written between the lines".<ref name='Séralini 2010-04-17'> {{cite web | url = http://www.criigen.org/SiteEn/index.php?option=com_content&task=view&id=188&Itemid=99 | title = CRIIGEN's Response to the Figaro | accessdate = 2010-07-21 | last = Séralini | first = Gilles-Eric | date = 2010-04-17 | work = The Committee for Research and Independent Information on Genetic Engineering | archivedate=2010-07-21|archiveurl = http://www.webcitation.org/5rNihFn4m}}</ref> Greenpeace also cited the study in a press report, in which it demanded that MON 863 be completely recalled from the global market and called for a strict review of current testing methods.<ref name='Greenpeace March 2007'> {{cite web | url = http://www.greenpeace.org/raw/content/international/press/reports/gp_briefing_seralini_study.pdf | title = Regulatory systems for GE crops a failure: the case of MON863. | accessdate = 2010-07-21 | format = PDF | publisher = [[Greenpeace]] | quote = Greenpeace demands an immediate and complete recall of MON863 from the global market. We also call upon governments to undertake an urgent reassessment of all other authorised GE products and a strict review of current testing methods.}}</ref>



==Legal status==

In December 2009, a second study was published in the [[International Journal of Biological Sciences]]. In the study, findings of hepatorenal toxicity were reaffirmed, and concerns of metabolic consequences were further raised.<ref name='IJBS 2009-12-10'> {{cite journal | title = A Comparison of the Effects of Three GM Corn Varieties on Mammalian Health | journal = International Journal of Biological Sciences | date = 2009-12-10 | first = Joël Spiroux | last = de Vendômois | coauthors = François Roullier, Dominique Cellier, Gilles-Eric Séralini | volume = 5 | issue = 7 | pages = 706-726| id = PMID 20011136 | url = http://www.biolsci.org/v05p0706.htm | accessdate = 2010-07-21}}</ref>

As of 2015, MON 863 is approved for cultivation in three countries: the United States, Japan, and Canada. The corn is approved for use in [[Australia]], [[Canada]], [[China]], the [[European Union]], [[Japan]], [[Mexico]], [[New Zealand]], [[Russia]], [[Singapore]], [[South Korea]], [[Taiwan]], and the [[United States]].<ref>Staff, ISAAA. Last updated July 27, 2015 [http://www.isaaa.org/gmapprovaldatabase/event/default.asp?EventID=87&Event=MON863 Event Name: MON863] See Authorizations tab. Accessed June 2, 2016</ref>


The Huffington Post concurred that Monsanto's 90-day study was insufficient to determine potential health effects, as chronic organ problems are rarely evident within such a short amount of time.<ref name='Goldstein 2010-03-18'> {{cite news | first = Katherine | last = Goldstein | coauthors = Gazelle Emami | title =Monsanto's GMO Corn Linked To Organ Failure, Study Reveals | date = 2010-03-18 | url = http://www.huffingtonpost.com/2010/01/12/monsantos-gmo-corn-linked_n_420365.html | work = The Huffington Post | accessdate = 2010-07-21}}</ref>



==See also==

==See also==

Line 51: Line 16:


==References==

==References==

{{reflist}}

{{reflist|2}}




{{Corn}}

{{DEFAULTSORT:MON 863}}

{{Genetic engineering}}

[[Category:Maize]]

[[Category:Genetically modified organisms in agriculture]]



[[fr:MON 863]]

{{DEFAULTSORT:Mon 863}}

[[Category:Genetically modified maize]]

[[Category:Monsanto]]


Latest revision as of 01:46, 25 March 2023

MON 863 is a genetically engineered variety of maize produced by Monsanto. It is genetically altered to express a modified version of Cry3Bb1, a delta endotoxin which originates from Bacillus thuringiensis.[1][2] This protects the plant from corn rootworm.[2][3] Unlike MON 810, Bt 11, and Bt 176 which each produce a modified Cry1Ab, MON 863 instead produces a modified Cry3Bb1 toxin and contains nptII, a marker gene for antibiotic resistance.[1][4]

History[edit]

In 2004, Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed[5] and in 2006 for use in food.[6] There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr Gilles-Éric Séralini, who was on the committee that reviewed MON863 for the French government.[7]

See Genetically modified food controversies for details of this controversy, which extended beyond MON 863.

Following legal action by parties including the Swedish Board of Agriculture and Greenpeace, a Münster appeals court ruled that Monsanto would be forced to publicly reveal its research data.[8]

Legal status[edit]

As of 2015, MON 863 is approved for cultivation in three countries: the United States, Japan, and Canada. The corn is approved for use in Australia, Canada, China, the European Union, Japan, Mexico, New Zealand, Russia, Singapore, South Korea, Taiwan, and the United States.[9]

See also[edit]

References[edit]

  1. ^ a b "The MON863 case - a chronicle of systematic deception" (PDF). Greenpeace. Retrieved 2010-07-22. MON863 is a genetically modified corn that expresses a Bt-toxin. This toxin is a modified version of the delta endotoxin Cry3Bb1 which originates from the microorganism Bacillus thuringiensis. The genetic manipulation is aimed at protecting maize plants against a pest called corn rootworm (Diabrotica spp.). MON863 differs from other Bt-corns already placed on the market (MON810, BT11, Bt176), which produce a modified Cry1Ab toxin conferring resistance to a pest called European corn borer (Ostrinia nubilalis), in that it produces an artificial Cry3Bb1 toxin. In addition to the modified Cry3Bb1 toxin gene MON863 contains an antibiotic resistance marker gene.
  • ^ a b Doull, J.; Gaylor, D.; Greim, H.A.; Lovell, D.P.; Lynch, B.; Munro, I.C. (2007). "Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863)". Food and Chemical Toxicology. 45 (11): 2073–85. doi:10.1016/j.fct.2007.08.033. PMID 17900781.
  • ^ Coghlan, Andy (2010-01-22). "Engineered maize toxicity claims roundly rebuffed". New Scientist. Retrieved 2010-07-21.
  • ^ Lorch, Antje (2005-09-30). "EFSA's Opinion on MON863 hybrids" (PDF). ifrik. Greenpeace. Archived from the original (PDF) on 2011-07-26. Retrieved 2010-07-22. MON863 contains an GM antibiotic resistance gene (nptII) against kanamycin and neomycin.
  • ^ Staff (8 August 2005) concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm Archived 2010-12-31 at the Wayback Machine Commission of the European Communities, Official Journal, Retrieved 17 November 2012
  • ^ Staff (13 January 2006) concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a maize product (Zea mays L., line MON 863) genetically modified for resistance to corn rootworm and in 2006 in food Archived 2012-09-05 at the Wayback Machine Commission of the European Communities, Official Journal, Retrieved 17 November 2012
  • ^ "Seralini bio on CRIIGEN". Archived from the original on 2014-03-30. Retrieved 2012-09-22.
  • ^ Reilly, Michael (2010-01-23). "Is Genetically Modified Corn Toxic?". Discovery News. Retrieved 2010-07-21.
  • ^ Staff, ISAAA. Last updated July 27, 2015 Event Name: MON863 See Authorizations tab. Accessed June 2, 2016


  • Retrieved from "https://en.wikipedia.org/w/index.php?title=MON_863&oldid=1146465889"

    Categories: 
    Genetically modified maize
    Monsanto
    Hidden categories: 
    Webarchive template wayback links
    Articles with short description
    Short description matches Wikidata
     



    This page was last edited on 25 March 2023, at 01:46 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki